Do Inflammatory Cytokines Affect Patient Outcomes After ACDF?

Study Design: Prospective cohort study. Objective: The aim was to determine the relationship between serum inflammatory mediators, preoperative cervical spine disease severity, and clinical outcomes after anterior cervical discectomy and fusion (ACDF). Summary of Background Data: Given the role of the inflammatory cascade in spinal degenerative disease, it has been hypothesized that inflammatory markers may serve as a predictor of patient outcomes after surgery. Materials and Methods: All patients over age 18 who underwent ACDF for cervical spondylosis with associated radiculopathy and/or myelopathy between 2015 and 2017 from a single institution were prospectively recruited. Preoperative serum inflammatory markers including interleukin (IL)-6, IL-8, tumor necrosis factor-α, high-mobility group box-1 (HMGB1), and white blood cells were measured and correlated to patient demographics, surgical characteristics, duration of symptoms, previous opioid use, and preoperative and 1-year postoperative patient-reported outcomes measures (PROMs) including the neck disability index (NDI), visual analog scale neck pain, visual analog scale arm pain, and Physical and Mental Component Scores of the Short Form-12 (PCS and MCS, respectively) using spearman’s rho coefficient. Results: A total of 77 patients were enrolled with follow-up PROMs available for 62% (n=48) of patients at a minimum of 1-year after ACDF. The absolute concentrations of IL-6 and tumor necrosis factor-α were found to be weakly correlated with one another (ρ=0.479). Preoperative symptoms lasting <1-year were weakly correlated with elevation in HMGB1 (ρ=0.421). All other patient demographics exhibited negligible correlation with the preoperative inflammatory markers. Lower preoperative PCS (ρ=0.355) and higher preoperative NDI (ρ=0.336) were weakly correlated with elevated HMGB1. Lower MCS (ρ=0.395) and higher NDI (ρ=0.317) preoperatively were weakly correlated with elevated white blood cells. Postoperative improvement in MCS (ρ=0.306) and MCS recovery ratio (ρ=0.321) exhibited a weakly positive correlation with IL-6. Conclusion: Preoperative cytokine levels demonstrated minimal correlation with preoperative symptoms or clinical improvement, suggesting that profiling of patient cytokines has limited utility in predicting outcomes after ACDF. Level of Evidence: Level III.

[1]  Abhirup Das,et al.  Degenerative Cervical Myelopathy: Insights into Its Pathobiology and Molecular Mechanisms , 2021, Journal of clinical medicine.

[2]  M. Nishibori,et al.  High Mobility Group Box-1 and Blood–Brain Barrier Disruption , 2020, Cells.

[3]  A. Vaccaro,et al.  Correlation of Early Outcomes and Intradiscal Interleukin-6 Expression in Lumbar Fusion Patients , 2020, Neurospine.

[4]  S. Erdoğan,et al.  Inflammatory cytokines IL-6 and TNF-α in patients with hip fracture , 2019, Osteoporosis International.

[5]  Bizeng Zhao,et al.  Interleukin-6 Serum Levels Are Elevated in Individuals with Degenerative Cervical Myelopathy and Are Correlated with Symptom Severity , 2018, Medical science monitor : international medical journal of experimental and clinical research.

[6]  Huan Yang,et al.  High mobility group box-1 (HMGB1) is increased in injured mouse spinal cord and can elicit neurotoxic inflammation , 2017, Brain, Behavior, and Immunity.

[7]  D. Rosenzweig,et al.  Surgical Treatment of Cervical Radiculopathy: Meta-analysis of Randomized Controlled Trials , 2017, Spine.

[8]  T. Albert,et al.  Long-term Evaluation of Cervical Disc Arthroplasty with the Mobi-C© Cervical Disc: A Randomized, Prospective, Multicenter Clinical Trial with Seven-Year Follow-up , 2017, International Journal of Spine Surgery.

[9]  Xun Ma,et al.  Inhibition of HMGB1 reduces rat spinal cord astrocytic swelling and AQP4 expression after oxygen-glucose deprivation and reoxygenation via TLR4 and NF-κB signaling in an IL-6-dependent manner , 2017, Journal of Neuroinflammation.

[10]  E. Akhmetzyanova,et al.  Systemic and Local Cytokine Profile following Spinal Cord Injury in Rats: A Multiplex Analysis , 2017, Front. Neurol..

[11]  M. Pagnano,et al.  No Correlation Between Serum Markers and Early Functional Outcome After Contemporary THA , 2017, Clinical orthopaedics and related research.

[12]  W. Maloney,et al.  Cytokines as a predictor of clinical response following hip arthroscopy: minimum 2-year follow-up , 2016, Journal of hip preservation surgery.

[13]  R. Dias,et al.  Association Between the Plasma Levels of Mediators of Inflammation With Pain and Disability in the Elderly With Acute Low Back Pain: Data From the Back Complaints in the Elders (BACE)-Brazil Study , 2016, Spine.

[14]  S. Ohtori,et al.  Single intradiscal injection of the interleukin-6 receptor antibody tocilizumab provides short-term relief of discogenic low back pain; prospective comparative cohort study. , 2016, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[15]  M. Fehlings,et al.  Degenerative Cervical Myelopathy: Epidemiology, Genetics, and Pathogenesis , 2015, Spine.

[16]  R. D. da Costa,et al.  Cytokine Concentrations in the Cerebrospinal Fluid of Great Danes with Cervical Spondylomyelopathy , 2014, Journal of veterinary internal medicine.

[17]  Dariusz Szukiewicz,et al.  The Role of Inflammatory and Anti-Inflammatory Cytokines in the Pathogenesis of Osteoarthritis , 2014, Mediators of inflammation.

[18]  I. Shapiro,et al.  Role of cytokines in intervertebral disc degeneration: pain and disc content , 2014, Nature Reviews Rheumatology.

[19]  T. Albert,et al.  Expression and Relationship of Proinflammatory Chemokine RANTES/CCL5 and Cytokine IL-1&bgr; in Painful Human Intervertebral Discs , 2013, Spine.

[20]  C. Kepler,et al.  The molecular basis of intervertebral disc degeneration. , 2013, The spine journal : official journal of the North American Spine Society.

[21]  M. McGirt,et al.  Assessment of the minimum clinically important difference in pain, disability, and quality of life after anterior cervical discectomy and fusion: clinical article. , 2013, Journal of neurosurgery. Spine.

[22]  G. Scuderi,et al.  Cytokine Expression in the Epidural Space: A Model of Noncompressive Disc Herniation-Induced Inflammation , 2013, Spine.

[23]  K. Kim,et al.  Cervical Radiculopathy due to Cervical Degenerative Diseases : Anatomy, Diagnosis and Treatment. , 2010, Journal of Korean Neurosurgical Society.

[24]  L. Setton,et al.  Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues. , 2010, Arthritis and rheumatism.

[25]  J D Bartleson,et al.  Cervical Spondylotic Myelopathy , 2010, The neurologist.

[26]  Joon Ho Wang,et al.  Comparison of growth factor and cytokine expression in patients with degenerated disc disease and herniated nucleus pulposus. , 2009, Clinical biochemistry.

[27]  H. Nagashima,et al.  Tumor necrosis factor-α, interleukin-1β, and interleukin-6 in the cerebrospinal fluid of patients with cervical myelopathy and lumbar radiculopathy , 2009, European Spine Journal.

[28]  N. Boos,et al.  Matrix metalloproteinase expression levels suggest distinct enzyme roles during lumbar disc herniation and degeneration , 2009, European Spine Journal.

[29]  A. Freemont,et al.  Modified expression of the ADAMTS enzymes and tissue inhibitor of metalloproteinases 3 during human intervertebral disc degeneration. , 2009, Arthritis and rheumatism.

[30]  Christine L. Weisshaar,et al.  Cytokine mRNA expression in painful radiculopathy. , 2009, The journal of pain : official journal of the American Pain Society.

[31]  H. Baba,et al.  Herniated and spondylotic intervertebral discs of the human cervical spine: histological and immunohistological findings in 500 en bloc surgical samples. Laboratory investigation. , 2008, Journal of neurosurgery. Spine.

[32]  J. Magaziner,et al.  Association Between Interleukin‐6 and Lower Extremity Function After Hip Fracture—The Role of Muscle Mass and Strength , 2008, Journal of the American Geriatrics Society.

[33]  Y. Matsuyama,et al.  Analysis of Interleukin-8, Interleukin-10, and Tumor Necrosis Factor-α in the Cerebrospinal Fluid of Patients With Cervical Spondylotic Myelopathy , 2008, Journal of spinal disorders & techniques.

[34]  K. Olmarker,et al.  The Role of Tumor Necrosis Factor-&agr; in Apoptosis of Dorsal Root Ganglion Cells Induced by Herniated Nucleus Pulposus in Rats , 2008, Spine.

[35]  S. Abram.  A Double-blind, Placebo-controlled, Dose-Response Pilot Study Evaluating Intradiscal Etanercept in Patients with Chronic Discogenic Low Back Pain or Lumbosacral Radiculopathy , 2008 .

[36]  Steven P. Cohen,et al.  A Double-blind, Placebo-controlled, Dose–Response Pilot Study Evaluating Intradiscal Etanercept in Patients with Chronic Discogenic Low Back Pain or Lumbosacral Radiculopathy , 2007, Anesthesiology.

[37]  S. Ohtori,et al.  Up-Regulation of Acid-Sensing Ion Channel 3 in Dorsal Root Ganglion Neurons Following Application of Nucleus Pulposus on Nerve Root in Rats , 2006, Spine.

[38]  L. Ginaldi,et al.  Osteoporosis, inflammation and ageing , 2005, Immunity & Ageing.

[39]  A. Freemont,et al.  The role of interleukin-1 in the pathogenesis of human Intervertebral disc degeneration , 2005, Arthritis research & therapy.

[40]  L. Haisheng,et al.  Cytokine profiles in conditioned media from cultured human intervertebral disc tissue , 2005 .

[41]  K. Olmarker,et al.  Inflammatory Cytokines Released from the Facet Joint Tissue in Degenerative Lumbar Spinal Disorders , 2004, Spine.

[42]  M. Lazdunski,et al.  How Nerve Growth Factor Drives Physiological and Inflammatory Expressions of Acid-sensing Ion Channel 3 in Sensory Neurons* , 2003, Journal of Biological Chemistry.

[43]  J. Fitzpatrick,et al.  Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. , 2002, The Journal of bone and joint surgery. British volume.

[44]  J. Weinstein,et al.  Quantification of neural tissue injury in a rat radiculopathy model: comparison of local deformation, behavioral outcomes, and spinal cytokine mRNA for two surgeons , 2001, Journal of Neuroscience Methods.

[45]  J. Hoyland,et al.  Degeneration of intervertebral discs: current understanding of cellular and molecular events, and implications for novel therapies , 2001, Expert Reviews in Molecular Medicine.

[46]  S. Emery,et al.  Anterior Cervical Decompression and Arthrodesis for the Treatment of Cervical Spondylotic Myelopathy. Two to Seventeen-Year Follow-up* , 1998, The Journal of bone and joint surgery. American volume.

[47]  M. Nakamura,et al.  MRI of cervical intervertebral discs in asymptomatic subjects. , 1998, The Journal of bone and joint surgery. British volume.

[48]  S. Rotshenker,et al.  Murine Nucleus Pulposus‐Derived Cells Secrete Interleukins‐1‐β, ‐6, and ‐10 and Granulocyte‐Macrophage Colony‐Stimulating Factor in Cell Culture , 1997, Spine.